Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Yahoo Finance · 2 weeks ago
Open | 774.02 |
High | 777.42 |
Low | 760.00 |
Mkt Cap | 722.31B |
P/E (TTM) | 112.43 |
Div & Yield | 5.20 & 0.68% |
Prev. Close | 771.55 |
52 Wk. Low | 419.80 |
52 Wk. High | 800.78 |
Related stocks
American pharmaceutical company
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 8.77B | 26.00% ▲ |
Net Income | 2.24B | 66.80% ▲ |
Diluted EPS | 2.58 | 66.40% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $2.75 | - |
Q1 2024 | $2.46 | $2.58 |
Q4 2023 | $2.22 | $2.49 |
S&P 500^GSPC | 5,222.68+8.60 (+0.16%) |
Dow 30^DJI | 39,512.84+125.08 (+0.32%) |
Nasdaq^IXIC | 16,340.87-5.40 (-0.03%) |
Bitcoin USDBTC-USD | 60,879.05-3.31% |
S&P 500^GSPC | 5,222.68+0.16% |
Oklo Inc.OKLO | 8.45-53.65% |